K
KDT Ventures focuses on early-stage, science-driven startups that are "re-architecting the world at a molecular level" by leveraging cutting-edge chemistry, biology, and computational disciplines. Their strategy involves being an early institutional investor in companies developing revolutionary products and technologies across sectors like therapeutics, digital health, industrial biotechnology, and climate.
Portfolio
6
Fund Size
$250M
Top Stage
Series A
Last 12 Mo
0
Stage Distribution
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| March Biosciences | Series A | $28.4M | Oct 2024 |
| ZymoChem | Series A | $21M | Jan 2024 |
| Faeth Therapeutics | Seed | $20M | Jan 2022 |
| 54gene | Series B | $25M | Sep 2021 |
| 54gene | Seed | $4.5M | Jul 2019 |
| Abridge | Seed|Series A | $15M | — |
Top Co-Investors
Union Square Ventures1 shared
Bessemer Venture Partners1 shared
Pillar1 shared
Toyota1 shared
GS Futures1 shared
Cavallo Ventures1 shared
Endeavor Catalyst1 shared
Ingressive Capital1 shared
4BIO Capital1 shared
Alexandria Venture Investments1 shared
Portal Innovations1 shared
Y Combinator1 shared
Fifty Years1 shared
Better1 shared
Khosla Ventures1 shared
Future Fund1 shared
S2G Ventures1 shared
Digitalis Ventures1 shared
Agfunder1 shared
Cantos1 shared
Last updated: 1 March 2026